Roche Holding AG (LTS:0QOK)
CHF 248.4 1.25 (0.51%) Market Cap: 201.45 Bil Enterprise Value: 231.01 Bil PE Ratio: 18.78 PB Ratio: 6.84 GF Score: 84/100

Q3 2019 Roche Holding AG Corporate Sales Call Transcript

Oct 16, 2019 / 12:00PM GMT
Release Date Price: CHF292.5 (+1.12%)
Operator

Ladies and gentlemen welcome to the Roche's Third Quarter 2019 Audio Webcast and Conference Call. I am Sharon, your Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Dr. Severin Schwan, CEO of Roche Group. Please go ahead.

Severin Schwan
Roche Holding AG - CEO & Executive Director

Thank you. And welcome, everybody, for -- and thank you for joining our Q3 briefing.

If we turn right to Slide 6. We have seen strong results in Q3 with 12% growth in Pharma, very much driven by the newly launched medicines; and 4% growth in diagnostics, actually accelerating in the third quarter, very much driven by Immunodiagnostics. So on a Roche Group level, year-to-date, 10% growth, 13% on a quarterly basis. And if you look at it into regional -- from a regional perspective, really all regions contributing to this result. Very much Pharma, of course, as in previous quarters. International

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot